| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
36,061 |
33,362 |
$2.49M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
39,559 |
37,044 |
$2.00M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
14,133 |
13,586 |
$1.07M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
6,703 |
6,513 |
$453K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
7,954 |
7,797 |
$435K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
11,750 |
11,320 |
$276K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
7,558 |
7,416 |
$256K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,601 |
2,570 |
$183K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,409 |
5,269 |
$155K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,111 |
2,091 |
$149K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,779 |
1,613 |
$111K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
9,323 |
9,056 |
$104K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
908 |
884 |
$100K |
| 84443 |
Thyroid stimulating hormone (TSH) |
8,364 |
8,108 |
$94K |
| 0002A |
|
4,746 |
4,684 |
$94K |
| 80061 |
Lipid panel |
10,080 |
9,825 |
$88K |
| 0001A |
|
5,053 |
4,974 |
$85K |
| 80053 |
Comprehensive metabolic panel |
11,755 |
11,344 |
$81K |
| 36415 |
Collection of venous blood by venipuncture |
25,741 |
24,061 |
$80K |
| 99421 |
|
8,304 |
7,775 |
$71K |
| 99215 |
Prolong outpt/office vis |
623 |
609 |
$67K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
4,756 |
4,659 |
$66K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,863 |
4,704 |
$57K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
674 |
657 |
$52K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,023 |
1,005 |
$50K |
| X5622 |
|
2,700 |
2,620 |
$47K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,373 |
1,347 |
$36K |
| 71046 |
Radiologic examination, chest; 2 views |
2,026 |
1,965 |
$33K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
6,690 |
6,224 |
$33K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,154 |
1,117 |
$33K |
| 92551 |
|
4,967 |
4,907 |
$32K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,041 |
1,006 |
$30K |
| 99188 |
|
3,656 |
3,609 |
$27K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
276 |
272 |
$23K |
| 82728 |
|
1,943 |
1,875 |
$21K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,290 |
3,090 |
$20K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
256 |
256 |
$20K |
| 96127 |
|
5,142 |
5,066 |
$19K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
750 |
722 |
$14K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
388 |
379 |
$14K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,784 |
1,752 |
$14K |
| 87081 |
|
2,795 |
2,705 |
$13K |
| 85027 |
|
2,422 |
2,325 |
$13K |
| 91320 |
|
151 |
133 |
$12K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
229 |
226 |
$12K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,184 |
1,695 |
$12K |
| 84439 |
|
1,871 |
1,797 |
$11K |
| 90686 |
|
3,633 |
3,569 |
$11K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
153 |
150 |
$10K |
| 99000 |
|
776 |
764 |
$10K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,474 |
1,403 |
$10K |
| 81001 |
|
3,487 |
3,350 |
$9K |
| 0054A |
|
218 |
217 |
$9K |
| 80050 |
General health panel |
201 |
199 |
$9K |
| 90480 |
|
306 |
299 |
$8K |
| 83550 |
|
1,041 |
1,016 |
$7K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
46 |
46 |
$7K |
| 87807 |
|
509 |
503 |
$7K |
| 82043 |
|
2,028 |
1,979 |
$6K |
| 90682 |
|
172 |
171 |
$6K |
| 87210 |
|
1,352 |
1,289 |
$6K |
| 0011A |
|
454 |
450 |
$6K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
244 |
237 |
$6K |
| 0012A |
|
404 |
396 |
$6K |
| 99173 |
|
5,009 |
4,957 |
$6K |
| 81025 |
|
681 |
657 |
$6K |
| 99443 |
|
75 |
66 |
$6K |
| 99442 |
|
202 |
122 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
593 |
503 |
$5K |
| 83540 |
|
1,069 |
1,042 |
$5K |
| 0071A |
|
122 |
121 |
$5K |
| 0072A |
|
116 |
110 |
$5K |
| 86803 |
|
335 |
329 |
$4K |
| 0004A |
|
116 |
114 |
$4K |
| 0031A |
|
329 |
310 |
$4K |
| T1013 |
Sign language or oral interpretive services, per 15 minutes |
104 |
85 |
$3K |
| 90651 |
|
253 |
240 |
$3K |
| 90670 |
|
1,305 |
1,285 |
$3K |
| 87506 |
|
12 |
12 |
$3K |
| 0124A |
|
104 |
100 |
$3K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
57 |
56 |
$3K |
| 85610 |
|
887 |
585 |
$3K |
| 36416 |
|
1,196 |
974 |
$3K |
| 99441 |
|
168 |
123 |
$3K |
| 85018 |
|
1,321 |
1,296 |
$3K |
| 83655 |
|
289 |
287 |
$2K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
167 |
164 |
$2K |
| 0064A |
|
63 |
62 |
$2K |
| 90715 |
|
295 |
280 |
$2K |
| 87186 |
|
250 |
238 |
$2K |
| 93000 |
|
233 |
229 |
$2K |
| 90662 |
|
30 |
30 |
$2K |
| 0052A |
|
38 |
38 |
$2K |
| 86780 |
|
188 |
181 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
180 |
168 |
$1K |
| 82947 |
|
563 |
547 |
$1K |
| G0008 |
Administration of influenza virus vaccine |
245 |
230 |
$1K |
| 0134A |
|
39 |
37 |
$1K |
| 0051A |
|
27 |
27 |
$1K |
| 80076 |
|
232 |
220 |
$1K |
| 76830 |
Ultrasound, transvaginal |
12 |
12 |
$1K |
| 90461 |
|
40 |
39 |
$896.35 |
| 82950 |
|
234 |
230 |
$888.78 |
| 84460 |
|
277 |
262 |
$807.50 |
| G0179 |
Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care |
29 |
26 |
$773.59 |
| 81003 |
|
353 |
346 |
$761.62 |
| 90473 |
|
63 |
63 |
$747.18 |
| 74019 |
|
25 |
25 |
$651.00 |
| 84703 |
|
300 |
287 |
$602.25 |
| 0082A |
|
12 |
12 |
$517.74 |
| 90656 |
|
316 |
315 |
$500.49 |
| 96161 |
|
265 |
250 |
$479.06 |
| 87088 |
|
53 |
51 |
$420.77 |
| 90474 |
|
80 |
80 |
$333.12 |
| 85652 |
|
198 |
193 |
$330.20 |
| 87340 |
|
26 |
24 |
$251.49 |
| 90716 |
|
164 |
161 |
$232.12 |
| 84450 |
|
41 |
38 |
$144.70 |
| 85379 |
|
12 |
12 |
$101.08 |
| 90633 |
|
626 |
616 |
$70.75 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
383 |
364 |
$48.67 |
| G0476 |
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test |
26 |
24 |
$45.87 |
| 90744 |
|
303 |
294 |
$29.28 |
| 90698 |
|
1,017 |
1,003 |
$17.66 |
| 90734 |
|
195 |
190 |
$12.79 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
59 |
56 |
$4.90 |
| 82570 |
|
14 |
12 |
$0.08 |
| 90710 |
|
27 |
26 |
$0.00 |
| 90707 |
|
45 |
45 |
$0.00 |
| 91300 |
|
369 |
350 |
$0.00 |
| 90681 |
|
108 |
107 |
$0.00 |
| 90685 |
|
138 |
135 |
$0.00 |
| 90672 |
|
29 |
29 |
$0.00 |
| 90696 |
|
113 |
112 |
$0.00 |
| 90680 |
|
44 |
44 |
$0.00 |
| 90697 |
|
13 |
12 |
$0.00 |
| 90619 |
|
25 |
25 |
$0.00 |
| 90677 |
|
54 |
52 |
$0.00 |
| 91301 |
|
15 |
15 |
$0.00 |